These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 24065545

  • 1. Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families.
    Rudnicka H, Debniak T, Cybulski C, Huzarski T, Gronwald J, Lubinski J, Gorski B.
    Mol Biol Rep; 2013 Dec; 40(12):6619-23. PubMed ID: 24065545
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Complex Characterization of Germline Large Genomic Rearrangements of the BRCA1 and BRCA2 Genes in High-Risk Breast Cancer Patients-Novel Variants from a Large National Center.
    Bozsik A, Pócza T, Papp J, Vaszkó T, Butz H, Patócs A, Oláh E.
    Int J Mol Sci; 2020 Jun 30; 21(13):. PubMed ID: 32629901
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing.
    Riahi A, Chabouni-Bouhamed H, Kharrat M.
    Cancer Genet; 2017 Jan 30; 210():22-27. PubMed ID: 28212807
    [Abstract] [Full Text] [Related]

  • 5. Large genomic rearrangements of BRCA1 and BRCA2 among patients referred for genetic analysis in Galicia (NW Spain): delimitation and mechanism of three novel BRCA1 rearrangements.
    Fachal L, Blanco A, Santamariña M, Carracedo A, Vega A.
    PLoS One; 2014 Jan 30; 9(3):e93306. PubMed ID: 24686251
    [Abstract] [Full Text] [Related]

  • 6. The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer.
    van der Merwe NC, Oosthuizen J, Theron M, Chong G, Foulkes WD.
    BMC Cancer; 2020 May 06; 20(1):391. PubMed ID: 32375709
    [Abstract] [Full Text] [Related]

  • 7. Frequency and distribution of BRCA1/BRCA2 large genomic rearrangements in Turkish population with breast cancer.
    Akin Duman T, Ozturk FN.
    J Hum Genet; 2023 Jul 06; 68(7):485-490. PubMed ID: 36864289
    [Abstract] [Full Text] [Related]

  • 8. Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.
    Górski B.
    Hered Cancer Clin Pract; 2006 Aug 15; 4(3):142-52. PubMed ID: 20223018
    [Abstract] [Full Text] [Related]

  • 9. Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.
    Stadler ZK, Saloustros E, Hansen NA, Schluger AE, Kauff ND, Offit K, Robson ME.
    Breast Cancer Res Treat; 2010 Sep 15; 123(2):581-5. PubMed ID: 20221693
    [Abstract] [Full Text] [Related]

  • 10. Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families.
    Kang P, Mariapun S, Phuah SY, Lim LS, Liu J, Yoon SY, Thong MK, Mohd Taib NA, Yip CH, Teo SH.
    Breast Cancer Res Treat; 2010 Nov 15; 124(2):579-84. PubMed ID: 20617377
    [Abstract] [Full Text] [Related]

  • 11. BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.
    Ratajska M, Brozek I, Senkus-Konefka E, Jassem J, Stepnowska M, Palomba G, Pisano M, Casula M, Palmieri G, Borg A, Limon J.
    Oncol Rep; 2008 Jan 15; 19(1):263-8. PubMed ID: 18097605
    [Abstract] [Full Text] [Related]

  • 12. BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland.
    Perkowska M, BroZek I, Wysocka B, Haraldsson K, Sandberg T, Johansson U, Sellberg G, Borg A, Limon J.
    Hum Mutat; 2003 May 15; 21(5):553-4. PubMed ID: 12673801
    [Abstract] [Full Text] [Related]

  • 13. Identification of large genomic rearrangement of BRCA1/2 in high risk patients in Korea.
    Kim DH, Chae H, Jo I, Yoo J, Lee H, Jang W, Park J, Lee GD, Jeon DS, Lee KH, Hur SY, Chae BJ, Song BJ, Kim M, Kim Y.
    BMC Med Genet; 2017 Mar 28; 18(1):38. PubMed ID: 28351343
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Genetic testing in Poland and Ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer?
    Nguyen-Dumont T, Karpinski P, Sasiadek MM, Akopyan H, Steen JA, Theys D, Hammet F, Tsimiklis H, Park DJ, Pope BJ, Slezak R, Stembalska A, Pesz K, Kitsera N, Siekierzynska A, Southey MC, Myszka A.
    Genet Res (Camb); 2020 Aug 10; 102():e6. PubMed ID: 32772980
    [Abstract] [Full Text] [Related]

  • 16. Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families.
    Pylkäs K, Erkko H, Nikkilä J, Sólyom S, Winqvist R.
    BMC Cancer; 2008 May 26; 8():146. PubMed ID: 18501021
    [Abstract] [Full Text] [Related]

  • 17. Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.
    Villarreal-Garza C, Alvarez-Gómez RM, Pérez-Plasencia C, Herrera LA, Herzog J, Castillo D, Mohar A, Castro C, Gallardo LN, Gallardo D, Santibáñez M, Blazer KR, Weitzel JN.
    Cancer; 2015 Feb 01; 121(3):372-8. PubMed ID: 25236687
    [Abstract] [Full Text] [Related]

  • 18. Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features.
    James PA, Sawyer S, Boyle S, Young MA, Kovalenko S, Doherty R, McKinley J, Alsop K, Beshay V, Harris M, Fox S, Lindeman GJ, Mitchell G.
    Fam Cancer; 2015 Jun 01; 14(2):287-95. PubMed ID: 25678442
    [Abstract] [Full Text] [Related]

  • 19. Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan.
    Rashid MU, Muhammad N, Amin A, Loya A, Hamann U.
    Breast Cancer Res Treat; 2017 Jan 01; 161(2):191-201. PubMed ID: 27826754
    [Abstract] [Full Text] [Related]

  • 20. Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer.
    Ramus SJ, Harrington PA, Pye C, DiCioccio RA, Cox MJ, Garlinghouse-Jones K, Oakley-Girvan I, Jacobs IJ, Hardy RM, Whittemore AS, Ponder BA, Piver MS, Pharoah PD, Gayther SA.
    Hum Mutat; 2007 Dec 01; 28(12):1207-15. PubMed ID: 17688236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.